Intuitive (ISRG) late Thursday said its next-generation robotic surgical system given 510(k) clearance by the US Food and Drug Administration for its da Vinci 5 multiport robotic system.
The new da Vinci 5 systems includes more than 150 enhancements from its predecessor devices, including improved accuracy and precision, 3D display and image processing and first-of-its-kind “force-sensing” tools.
Intuitive is expecting da Vinci 5 will be first available for a handful of US customers who collaborated with the company during its development, providing additional data about the new device ahead of a wider release.
Intuitive shares were 3% higher in after-hours activity.